$NVOS News
Last published 2y ago
- 2y agoNVOSNovo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial ResultsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and
- 2y agoNVOSNovo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing ProgramBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announced today that it has received notice of the commencement of disbursement for the complete monetization of a Standby Letter of Credit
- 2y agoNVOSNovo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing ProgramBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announced today that it has received confirmation of the issuance of a Standby Letter of Credit ("SBLC") by HSBC for delivery by Swift MT760, as
- 2y agoNVOSNovo Integrated Sciences' Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 MillionBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today announced the Company's Board of Directors has approved an increase of up to $10 million maximum amount, from the previously announced up to
- 2y agoNVOSAcenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein ProductsBusiness WireProject investment amounts expected to total $5.4 million with Acenzia investing $600 thousand, Protein Industries Canada investing $2.3 million, and two other partner companies investing $2.5 million Novo Integrated
- 2y agoNVOSNovo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory NoteBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announced today the Company and RC Consulting Consortium Group LLC, in favor of SCP Tourbillion Monaco ("RC"), have amended the prepayment terms and
- 2y agoNVOSNovo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase ProgramBusiness WireAs previously reported, the Board of Directors (the "Board") of Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") approved the repurchase of up to $5 million of the Company's outstanding common
- 2y agoNVOSNovo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing ProgramBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announced today that as part of a program to monetize a Standby Letter of Credit ("SBLC"), the Company has received written confirmation that a
- 2y agoNVOSNovo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial ResultsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and
- 2y agoNVOSNovo Integrated Sciences Closes on $6,210,000 Securities Purchase AgreementBusiness WireBoth the Mast Hill $3,500,000 Note and the FirstFire $277,777 Note were Paid in Full with Cash Proceeds from the Streeterville Note Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announced
- 2y agoSYTHTCRHOURFUBO+7CRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICAPR NewswireAnthony, Linder & Cacomanolis, PLLC is proud to announce that Partner Craig D. Linder has been selected to the 2024 Top 50 Lawyers in America list...
- 2y agoNVOSNovo Integrated Sciences Provides Update on Certain Current Actions and EventsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today provides an update with respect to certain actions and events, as follows: Purchase and Sale Agreement – Ophir Collection: As previously
- 2y agoNVOSNovo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.Business WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), and Clinical Consultants International, LLC ("CCI"), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Services Agreement
- 2y agoNVOSNovo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory NoteBusiness WireThe Waiver Exempts any determination of non-compliance associated to Nasdaq's Minimum Bid Price Requirement Rule Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announces today the Company has
- 2y agoNVOSNovo Integrated Sciences Appoints New PresidentBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announces today Mr. Robert Oliva has been appointed as the Company's new President. Mr. Oliva succeeds Mr. Christopher David, who remains as the
- 2y agoNVOSNovo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial ResultsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and
- 2y agoNVOSBlacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated SciencesBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") announces today Blacksheep Trust ("Blacksheep"), a New York-based private express trust settled for the purposes of Benevolent Services with (i) a
- 2y agoNVOSNovo Integrated Sciences Reports 2023 Fiscal Year Financial ResultsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and
- 2y agoNVOSNovo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. IndiaBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") proudly announces the signing of a Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India ("PCHPL"). This partnership initiates a
- 2y agoNVOSNovo Integrated Sciences' Purchase and Sale Agreement to Acquire Ophir Collection Receives Court ApprovalBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") today announced the United States District Court for the Central District of California has approved the Purchase and Sale Agreement ("PSA") which
- 2y agoNVOSNovo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price RequirementBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") today announced the Company has received notice from The Nasdaq Capital Market, LLC ("Nasdaq"), dated November 22, 2023, informing Novo that it has
- 3y agoNVOSNovo Integrated Sciences Announces Reverse Stock SplitBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today announced that the Company will undertake a reverse stock split of its common stock at a ratio of 1-for-10 (the "Reverse Stock
- 3y agoNVOSNovo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business DaysBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") today announced that RC Consulting Group LLC ("RC") has advised that the final phase for the withdrawal/payment to Novo of the unsecured 15-year
- 3y agoNVOSNovo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed BondBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") today announced the issuance of the underlying One Billion Dollar gold backed bond (the "Bond") specific to the previously disclosed Master
- 3y agoNVOSNovo Integrated Sciences' Board of Directors Approves $5 Million Stock Repurchase ProgramBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today announced the Company's Board of Directors has approved the repurchase of up to $5 million of the Company's outstanding common stock
- 3y agoNVOSNovo Integrated Sciences Provides Update on Certain Current EventsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") today provides an update with respect to the following previously disclosed pending transactions: (i) the Blacksheep Trust One Billion Dollar Master
- 3y agoNVOSNovo Integrated Sciences Signs Master Collateral Transfer AgreementBusiness WireOne Billion Dollar Collateral Transfer through Blacksheep Trust Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today announced Novo and Blacksheep Trust have signed a One Billion Dollar Master
- 3y agoNVOSNovo Integrated Sciences Provides Update on Certain Current Actions and EventsBusiness WireSeptember 29, 2023 Shareholder Meeting Voting Update Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today provides an update with respect to certain actions and events, as follows: Annual
- 3y agoNVOSNovo Integrated Sciences' IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey's Ministry of HealthBusiness WirePartners with NOYEM Global Foreign Trade and Consultancy Inc. for Distribution in Turkey Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today announced that its IoNovo for Kids pure iodine
- 3y agoNVOSNovo Integrated Sciences Provides Update on Potential Share Repurchase ProgramBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today provides an update with respect to the Company's Board of Directors (the "Board") conducting a strategic review of the Company to include
- 3y agoNVOSNovo Integrated Sciences Receives Underwriter Clearance Notice for $70,000,000 CouponBusiness WireCompliance Review Affirmed for Completion of Debt Funding Transaction Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today announced the Company received an Underwriting Clearance Notice from
- 3y agoNVOSNovo Integrated Sciences' IoNovo Iodine Granted Registration Number and Regulatory Approval by Turkey's Ministry of HealthBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today announced that its IoNovo Iodine product has been granted a registration number and received regulatory approval by Turkey's Ministry of
- 3y agoNVOSNovo Integrated Sciences Provides Update on Certain Current Actions and EventsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today provides an update with respect to certain actions and events, as follows: Parties continue to work toward closing SWAG Agreement: As
- 3y agoNVOSNovo Integrated Sciences and Farm 7 Group Announce Joint Venture for Kenya Cooperative Agricultural ProjectBusiness WireFood-based commodity farming on up to 9 million hectares in Kenya Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") today announced the Company and Farm 7 Group Inc., a Canada corporation ("F7"),
- 3y agoNVOSNovo Integrated Sciences Reports Fiscal Year 2023 Third Quarter Financial ResultsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and
- 3y agoNVOSNovo Integrated Sciences Receives $40,000,000 Commitment to Develop Eldercare Facilities in CanadaBusiness WireJoint Venture Collaboration with Sheikh Khaled bin Mohammad bin Fahad Al Thanayan and his Global Healthcare Organization Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") today announced the
- 3y agoNVOSNovo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial ResultsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and
- 3y agoNVOSNovo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial ResultsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and
- 3y agoNVOSNovo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt Instrument with a Principal Sum of $70,000,000Business WireThe Company to Receive a Lump Sum of $57,000,000 Note has a non-compounding yield of 1.52% (zero coupon) per annum Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today announced the issuance
- 3y agoNVOSNovo Integrated Sciences Reports Fiscal Full Year 2022 Financial ResultsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and
- 3y agoNOVO.B-DKNVOSPeople taking obesity drugs Ozempic and Wegovy gain weight once they stop medicationCNBCSome people may actually gain back more weight than they initially lost after stopping obesity drugs Ozempic and Wegovy.
- 3y agoNVOSNovo Integrated Sciences Provides Update on Certain Current Actions and EventsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today provides an update with respect to certain actions and events, as follows: As previously reported, on December 23, 2022, Novo entered into
- 3y agoNVOSNovo Integrated Sciences Announces Receipt of Notice from NasdaqBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today reported that it received a notice on January 25, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq")
- 3y agoNVOSNovo Integrated Sciences Provides Update on Certain Current Actions and EventsBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today provides an update with respect to certain actions and events, as follows: As previously reported, on December 23, 2022, Novo entered into
- 3y agoNVOSNovo Integrated Sciences Announces Receipt of Notice from NasdaqBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today reported that it received a notice (the "Notice) on December 15, 2022 from the Listing Qualifications Department of The Nasdaq Stock Market
- 3y agoNVOSNovo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.Business WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), and Clinical Consultants International LLC ("CCI"), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Agreement (the
- 4y agoNVOSNovo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.Business WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), and Clinical Consultants International ("CCI"), a Novo wholly-owned subsidiary, today announced the signing of a Sales and Consulting Agreement
- 4y agoNVOSNovo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle SolutionsBusiness WireTranquility's technology platform enhances the overall level of care and data integration of Home Care for seniors Tranquility's technology is complementary to Novo's holistic approach to patient-first health and
- 4y agoNVOSNovo Integrated Sciences, Inc. Announces Pricing of $2.0 Million Public OfferingBusiness WireNovo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), today announced the pricing of its public offering of an aggregate of 4,000,000 units at a public offering price of $0.50 per unit.
- 4y agoNVOSNovo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, SofthreadBusiness WireThrough the agreement, CCI will support Softhread's entrance into the rapidly evolving Health Care 4.0 ecosystem for health care delivery Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), and